To investigate the structural and genetic basis of the T cell response to defined peptide/major histocompatibility (MHC) class II complexes in humans, we established a large panel of T cell clones (61) from donors of different HLA-DR haplotypes and reactive with a tetanus toxin-derived peptide (tt830-844) recognized in association with most DR molecules (universal peptide). By using a bacterial enterotoxin-based proliferation assay and cDNA sequencing, we found preferential use of a particular VB region gene segment, VB2.1, in three of the individuals studied (64%, n = 58), irrespective of whether the peptide was presented by the DR6wcI, DR4w4, or DRw11.1 and DRw11.2 alleles, demonstrating that shared MHC class II antigens are not required for shared V/~ gene use by T cell receptors (TCRs) specific for this peptide. Vot gene use was more heterogeneous, with at least seven different Vc~ segments derived from five distinct families encoding ot chains able to pair with V132.1 chains to form a tt830-844/DR-specific binding site. Several cases were found of dories restricted to different DR alleles that expressed identical VI3 and (or very closely related) Vo~ gene segments and that differed only in their junctional sequences. Thus, changes in the putative complementary determining region 3 (CDR3) of the TCR may, in certain cases, alter MHC specificity and maintain peptide reactivity. Finally, in contrast to what has been observed in other defined peptide/MHC systems, a striking heterogeneity was found in the junctional regions of both c~ and 13 chains, even for TCRs with identical Vol and/or VI3 gene segments and the same restriction. Among 14 anti-tt830-844 clones using the V/32.1 gene segment, 14 unique VI3-D-JI3 junctions were found, with no evident conservation in length and/or amino acid composition. One interpretation for this apparent lack of coselection of specific junctional sequences in the context of a common V element, VB2.1, is that this V region plays a dominant role in the recognition of the tt830-844/DR complex. l~ cognition by T cells of antigens presented in the form of short peptide fragments bound to self-MHC molecules is mediated through a clonotypic cell surface heterodimer receptor (TCR) composed of an o~ and 13 chain (1, 2). The TCR specificity resides in the amino terminal ot and 13 variable domains which are generated as a result of combinatorial juxtaposition of germline-encoded V, D (for the 13 chain), and J gene segments and by somatic diversification mechanisms operating at the Vol-Jcx and VIJ-D-JB junctions (reviewed in reference 3).
l~
cognition by T cells of antigens presented in the form of short peptide fragments bound to self-MHC molecules is mediated through a clonotypic cell surface heterodimer receptor (TCR) composed of an o~ and 13 chain (1, 2) . The TCR specificity resides in the amino terminal ot and 13 variable domains which are generated as a result of combinatorial juxtaposition of germline-encoded V, D (for the 13 chain), and J gene segments and by somatic diversification mechanisms operating at the Vol-Jcx and VIJ-D-JB junctions (reviewed in reference 3).
Amino acid sequence comparison of the cr and 13 V regions with their Ig counterparts have shown a remarkable conservation of residues critical for maintaining the basic architecture of the Ig V regions (4, 5) . Thus, although the threedimensional structure of the TCR is not yet known, it has been predicted that its V regions fold and pair similarly to Ig V regions (3) (4) (5) . Furthermore, the identification of hypervariable regions in both c~ and/3 subunits (more evident, however, for the 13 chain) at sites corresponding approximately to the Ig CDRs 1, 2, and 3 (6) (7) (8) , suggests that in the TCR these regions contribute to the interaction with the peptide antigen/MHC complex. However, in contrast to Igs, somatic mutations in the rearranged TCK V gene segments do not appear to play a significant role in the generation of diversity (9) , implying, perhaps, that preservation of the germlineencoded CDKs is an important factor in maintaining TCR specificity.
Structural analysis of T cell responses to defined peptide/MHC class II complexes in the.mouse has indicated that TCKs with the same specificity tend to use a limited set of V gene segments (10o18), and that the use of particular Vot (10, 11, 13) or V/3 (10-12) segments correlates with antigen or MHC recognition. Moreover, TCRs using the same V gene segments often have been found to express very similar junctional sequences in both length and amino acid composition (14) (15) (16) (17) (18) , arguing in favor of a key role of these junctional regions in the recognition of a given antigen/MHC class II complex.
In the present study we sought to obtain further insights into the molecular mechanism of antigen and MHC recognition. As a model system we chose to analyze the V region structural components of HLA-DR-restricted TCRs selected in response to an epitope defined by a short synthetic peptide comprising residues 8300844 of tetanus toxin (tt) 1 (19) . Previous investigations have established that this peptide is universally immunogenic, since it is recognized in all tetanus toxoid (TT)-primed donors tested irrespective of their DR haplotype (20) , and that it appears to bind to different DR molecules in a similar orientation as demonstrated by experiments using truncated and substituted peptide (20, 21) ; and by the fact that some (promiscuous) clones recognize the peptide bound to several (up to five) different MHC alleles (21, 22) . This system therefore allows one to evaluate the impact of restricting element polymorphism on the structure of TCRs specific for the same immunogenic peptide. This polymorphism may determine both the way in which a peptide binds to a particular MHC molecule and its interaction with the TCR (23) .
We established a large panel of anti-tt830-844 T cell clones restricted to the same or different DR alleles from several TT-primed donors with distinct HLA-DR haplotypes and asked whether and at which level structural constraints are imposed on the corresponding TCKs. Our results indicate that a particular VB region, encoded by the V~2.1 gene segment, is strongly selected in different individuals in the antitt830-844 response regardless of the DR allele (DRw6cI, DR4w4, DRw11.1, and DKw11.2) presenting the antigen. This suggests that this VB region may interact with a common structural element of these complexes. We then analyzed the Vc~ segments expressed by 14 V~2.1-positive clones, most of them restricted to the DKw6cI allele, and found that at least seven different ones could be used to form anti-tt8300844 specificities. It is surprising to note that, in contrast to the apparent coselection of similar junctional sequences in the context of common V elements reported in other model 1Abbreviations used in this paper: A-PCR, anchored polymerase chain reaction; MBP, myelin basic protein; TSST-1, Staphylococcus toxic shock syndrome toxin 1; tt, tetanus toxin; TT, tetanus toxoid. systems, the junctional regions of both the ot and ~ chains of these TCRs were extremdy diversified, even for TCRs using the same Vot and VB gene segments and restricted to the same DR molecule. These data indicate a limited conservation of TCR V region components selected in response to the antigen/MHC complexes studied, and are discussed in the context of possible models of TCR/Ag/MHC recognition.
Materials and Methods
Isohtion of l~pti&-specific T Cell Clones. The tt830-844-specific T cell clones were isolated from PBMC of HLA-typed TT-primed donors, and characterized as previously described (20) . The isotype of class II molecules recognized by each T cell clone was determined by antibody blocking experiments, and the DK restricting alleles were identified by using a panel of HLA-DR homozygous EBV B cells as APC (20) .
Antigens. Peptide tt830-844, corresponding to amino acids 830-844 of tt (QYIKANSKFIGITEL), was mapped and synthesized as described (19 
PCR A raplification and Sequence Analysis of TCR-ct and-B eDNA.
Total KNA was prepared from 5-10 x 106 ceils by the acid guanidininm thiocyanate-phenol-chloroform extraction method (24) . Yields were usually 5-10 #g of total RNA for 106 cells. A previously described anchored-PCR (A-PCK) technique (25) was used with slight modifications. Single-strand eDNA was obtained using reagents from a eDNA synthesis kit (Boehringer Mannheim Corp., Indianapolis, IN). 5 #g of total RNA was used for each synthesis that was performed in 20 #1 for 1.5 h at 42~ according to the manufacturer's instructions. The reaction mixture was then precipitated by isopropanol in I M ammonium acetate to eliminate free nucleotides and the oligo(dT) primer. A poly(dG) tail sequence was then added to the sscDNA with terminal deoxynucleotidyl transferase (IBI, New Haven, CT) in a 40-#1reaction mixture containing a cobalt TdT buffer (IBI), and 0.1 mM dGTP for 30 min at 37~ Amplification of ~ and B variable regions were performed with Thermus aquaticus ~aq) polymerase (Perkin Elmer Cetus Corp., Norwalk, CT) by using 10% of the G-tailed sscDNA in the standard buffer containing 50 pmol of each of two oligo-primers in a final volume of 100 #1. One of the two primers contained a sequence (underlined) complementary to the poly(G) (5'-CACTCGAGC-GGCCGCGTCGACCCCCCCCCC-Y), and the other contained a sequence complementary to either the 5' end of,', constant region ( 5'-GCGAATTCAGATCTTAGCK;AGACAGACTTGTCA~ -3'), or the 5' end of/~ comtant region (5'-GC'IUTAGAG'~GACGC~ CTGCTCAGGCAGTA_TCTGGAGT-Y). The latter primer and a V/82-specific primer (5'-GCGAATTCGTCGACATACGAGCA-AGGCGTCGAGAAGG-Y) were used to detect expression of V/82 in GC clones. Amplification primers contained, in addition, restriction sites used for cloning. Each reaction mixture was subjeered to a denaturation step at 940C for 5 min, then to 25 amplification cycles in a thermocycler (Hybaid, Teddington, Middlesex, UK), each consisting of a 10-s denaturation step at 940C, a 1-min annealing step at 550C, a 15-s primer stabilization at 60~ and a 45-s elongation step at 720C. A final extension step at 72~ for 5 min terminated the reaction. PCK products were digested with Sail and BgllI restriction enzymes. The Sail site was located in the anchor-oligo-primer and BgllI site in the ot constant specific primer or in the/8 constant region. Amplified products (of ,o600-700 bp) containing c~ or/8 variable regions were agarose gel purified, subcloned into the M13mp19 bacteriophage vector, and sequenced according to the dideoxynucleotide termination method (26) . Sequencing primers were either the universal MD forward primer (U.S. Biochemical Corp., Cleveland, OH) or ~ or fl specific primers: 5'-GCGAA-T TCAGATCTTAGGCAGACAGACTTGTC ACTGC~Y, complementary to the c~ constant region; 5'-TCTGCTTCTGATGGCT-CAAAC-Y, complementary to the/8 constant region; 51CCG -GGGTATIGCACATACCA-Y, 5tCCAGGATCCTG~CCA-Y, and 5'-CAAGGGTCCTGCCGAAACCA-Y, degenerated primers complementary to a consensus sequence located in the ct variable region and 5'-CCCAGGGTCTGTCGGTACCA-3', a degenerated primer complementary to a consensus sequence in the/8 variable region. Several independent MD subclones (usually 5-10) were sequenced because PCR amplification is known to introduce errors through base misincorporation (27) , and because the ~ (and possibly the B) loci of both chromosomes may undergo functional rearrangements (28, 29) . Sequence homology comparisons with sequences obtained from GenBank were performed by using the Fastp program (30) , and MV10000 computer facilities (Centre de calcul, Pasteur Institute, Paris, France).
Northern Blot Analysis of V/82 Expression. For each clone, 2.5 /~g of total RNA was denatured at 65~ in formamide buffer, and electrophoresed on 1.3% agarose gels containing 1.7% formaldehyde. RNAs were then transferred to nylon membranes (Hybond, Amersham, UK), using a Fast trans apparatus (Genofit, Geneva, Switzerland), and filters baked for 2 h at 80~ Filters were prehybridized for 2.5 h at 650C in Church's buffer (0.5 M phosphate buffer, pH 7.2, 7% SDS). Hybridization was performed for 4 h at 65~ in the same buffer containing 2 • l& cpm/ml of [32p]random-priming-labeled (31) V/82.1 eDNA probe. The probe was derived from a human T cell clone (GM2.11) (20) that was found to express Vfl2.1 as detected by nucleotide sequencing (data not shown), and by specific PCR amplification as described above. The amplified DNA was digested with PatI restriction enzyme to remove the junctional region and V/8 fragment purified on an agarose gel. Hybridized filters were washed twice in 2x SSC, 0.1% SDS, then once in lx SSC, 0.1% SDS at 65"C. Membranes were exposed overnight to Kodak X-OMAT AR film using an intensifying screen.
HLA-DR Typing. The DR phenotyping of donors GC, KK, GAK, and BDM was assigned by serological typing (20) . The DR phenotype of GC was also determined by PCK and hybridization with a DRw11.l-specific oligonucleotide (Dr. G. Mazzola, Torino, Italy, personal communication). To obtain the precise HLA-DR allele expressed by donors AL (previously reported to be homozygous DRw13 [w6] by serological typing [20] ) and donor BK, typing was performed by PCR amplification and sequencing of the first domain of the HLA-DR/8 chain using eDNA prepared as described above. Amplification primers were 5'-GTTCTAGAGTCGACG-GC~ACACCGGACCACGTTCC-Y and 5'-CACGAATTCGG-ATCCTCGCCGCTGCACTGTGAAGC-Y, complementary to the 5' and 3' regions of the first domain of the HLA-DR B chain, respectively, (32) which allowed amplification of HLA-DR /81, /83, and /84 isotypes. Thus, to obtain at least a few representative sequences for each allele, 10 and 20 independent sequences were determined from donors AL and BK, respectively. When cDNAs corresponding to the TCK 13 chains of a number of clones from donors AL and BK were isolated by the A-PCR technique (25) and sequenced, it was found that the majority used a V~2 gene family member, V/32.1. In both donors we found two V/32.1 sequences, one that matched a previously published sequence (33) , referred to as V/32.1a (34) , and the other that differed by a single nudeotide substitution resulting in an Arg instead of a Trp at amino acid position 10 (numbering according to Kabat et al. [35] , not shown). This latter sequence is likely to represent an alldic variant of V/32.1 that has been named V/32.1c, to distinguish it from a third allde, V/32.1b, that differs from V/32.1c by a single amino acid (Lys 42 substituted by Gin) (34) .
Results

Preferential
T ceUs expressing Vf32 have been reported to proliferate in response to TSST-1 superantigen bound to class II MHC molecules (36) . To determine whether this property could be used to rapidly and reliably check for V/32 expression, 16 AL clones were tested both for their ability to respond to TSST-1 presented by autologous EBV-transformed B cell lines, and for V/32.1 expression by Northern blot hybridization analysis. The results presented in Fig. 1 demonstrate a perfect correlation between a proliferative response to TSST-1 and expression of V/32.1. These data also indicate that the substitution at amino acid position 10 that accounts for the two V/32.1 alleles does not affect the interaction with TSST-1. Altogether, 13 of 21 clones (,v60%) from AL and four of eight (50%) from BK all restricted to DKw6cl, proliferated in response to TSST-1 (Table 1 ). In addition, four of eight clones (50%) from donor BR that recognized tt830-844 in the context of DK4w4 were positive in the TSST-1 stimulation assay (Table 1) .
Sequencing of TCK-/3 cDNAs of 15 TSST-l-responsive clones from donors AL and BR indicated that, as expected, all expressed V/32.1 (Table 2 ). In contrast, 14 unique V/3-D-J/3 junctional sequences were found (Fig. 2 ). Clones AL8.1 and ALl2.1, which used the same Vot and V/3 gene segments and had identical ot and/3junctional sequences, were derived 
Most of the clones proliferated in response to low concentration of peptide (0.02-1 #g/ml) as well as to the native tt molecule presented by autologous APC, demonstrating that these clones are indeed tetanus specific. * The nomenclature of each DR allele is according to reference 32. * VB2 expression was assessed by TSST-1 proliferation assay (described in Materials and Methods) for all the clones indicated except for three clones from donor GC where VB2.1 expression was determined by PCR using VB2.1-and C/~-specific primers (data not shown).
from two independent in vitro primary cultures, strongly suggesting that the same clone present in PBMC had been independently isolated twice. Thus, 14 anti-t*830-844 clones from two donors, each expressing an independent ~ rearranging event, used V32.1. To determine whether other VB germline gene segments were preferentially used in the anti-*t830-844 response, a sample of eight TSST-l-unresponsive clones (three each from donors AL and BR, and one each from donors KK and GAK; Table 1 ) was subjected to sequence analysis. As expected, V32.1 was not expressed in any of these clones (Table 2) . Furthermore, in contrast to the repeated usage ofV32.1, no selected use of other V3 gene segments emerged since the AL clones expressed V~21.3, V~6.9, and V~19.1, the BR clones V/38.3, V313.6 (a new member of this gene family; Fig. 3 ), and V37.2, and the KK and GAR clones V/~12.3 and V319.1, respectively. No significantly greater degree of amino acid sequence identity could be demonstrated between VB2.1 and any of these gene segments ('~30%), than between V32.1 and members of other V3 families.
As V32.1 was found to be used by TCRs restricted to two distinct DR alleles (DRw6cI and DR4w4), we tested whether anti-tt830-844 clones isolated from a third donor, GC (homozygous D Rw11.1), also preferentially used V32.1. This haplotype was particularly interesting as 10 of 17 VB2.1-positive, DRw6cI-restricted clones from individuals AL and BR were promiscuous for DRw11.1 and/or DRw11.2 (Tables  1 and 2 ). It was found that 16 of 21 clones (76%) from donor GC expressed V~2.1, as indicated by proliferation to TSST-1 and/or PCR (Table 1 ).
In conclusion, the above results indicate that, at least in certain individuals, V~2.1 is strongly selected for recognition of tt830-844 whether presented by any of three different DR alleles, and suggest that this V segment may be interacting with a structural determinant common to these DR complexes.
Anti-tt830-844 Clones Display a Profile of Vol Gene Use that May Be Particular to Each Donor.
We then investigated whether, as observed for V~ particular Vot family members were also selected in response to tt830-844 by determining the nudeotide sequences of the Vot segments expressed in clones whose V~s had been characterized (Table 2) . Two distinct ~ sequences were often found in a given clone, although in two-thirds of the cases one of the two was the result of a nonproductive rearrangement (i.e., VoeJol junction not in frame, indicated by * in Table 2 ). In clones AL4.1, ALIII6.3, BR7.5, and GAR9.2, two functional ol chains were detected. In each of these clones, sequencing of 8-10 independent ~/ cDNAs did not reveal the presence of a second V~ suggesting that the expression of two cr chains is likely to be due to lack of allelic exclusion at the level of a rearrangement (28) , rather than to contamination by a second T cell done. In the remaining clones, a single Va could be detected in 5-10 independent cDNAs sequenced. It is of interest that, besides the unique human Ca sequence described (43), we found a variant in individual AL in which Ash at position 120 of the C region is replaced by Lys (Hg. 2) as the result of a single nucleotide substitution. This could correspond to an allelic variant of Cc~, because in the AL donor, both forms were found in different clones and, when two a sequences (out of frame, not shown, or in frame, Fig. 2 ) were present in a given done, each of them expressed one of these two forms. This further reinforces the notion of lack of allelic exclusion for ol chain rearrangement.
As shown in Table 2 , clones from donor AL preferentially used the Va21.1 and Va17.1 family members, each in at least 3 and potentially 4 of 10 clones, whereas in the BK donor, two members of the Va2 family, Va2.2, and 2.6, are expressed in 4 (or 5) of 10 clones. Thus, individuals AL and BK display similar high frequencies of V132.1 use (~>50%), and their profile of Va use is more heterogeneous and shows considerably less overlap. Some shared use of Va gene segments, however, does occur, in that Vc~l family members are expressed in clones AL9.2, BK7.3, and BK22.5, and Va8 family members are found in clones AL8.1, BR1.7, BR7.5, and GAR9.2. Nevertheless, certain gene segments appear to be preferentially used in each individual. A new Vc~ family (Va30), a new member of the Va14 family (Va14.1), and a new Jol gene segment (AL 6.3) were identified (Fig. 3) .
Multiple Combinations of Va and V[3 Gene Segments Are
Found to Constitute TCRs Specific for tt830-844. As shown in Table 2 , a rather diversified repertoire ofVc~ germline gene segments coexpressed with Vf52.1 was evident, although repeated use of the same or a related Va was found in a number of cases. Thus, in donor AL, Va21.1 was expressed in clones AL15.1 and ALIII6.1, and Va17.1 was found in clones ALIII4.3, AL17.1, and AL4.1, although in the latter clone Va14.2 could also potentially pair with V/32.1. In donor BK, two Va2 members, Vex2.2 and Va2.6, which are 72% identical at the amino add level, were found associated with V132.1 in two and, potentially three, DRw6cI-restricted clones. In both donors, two additional Va gene families, Va8 and Val, could also pair with V132.1. Altogether, at least seven different Va gene segments derived from five distinct families can encode a chains able to pair with V132.1 chains to form a tt830-844/DK-specific binding site. Of note, however, is that Va21.1, Va17.1, Va2.2, and VolS.1 (Vc~8.2), among the Va segments found in association with VB2.1, display a (39) . TheJB segments were described by Toyonaga et al. (40) . Jot sequences were assigned to previously described Jot gene segments (37, 41, 42) . * Clones in which a second, out-of-frame, sequence was detected. S Sequences corresponding to new V and J segments not yet described: Vot14.2, Vot30, JotAL-6.3, and VB13.6 (see Fig. 3 ). II A second in-frame V~ sequence (Vfl17.1-Jf12.6) has been found in one of nine independent sequences from this clone.
significantly higher degree of similarity to each other (50-60% amino acid identity) than to members of other Vc~ families (<40%), with the exception of Vc~15 and Vo~23 (not shown). An interesting situation was noticed for the three V/$2.1-positive dones from BR restricted to DR4w4. Clone BR1.7 shares the same Vc~ gene segment, Vo~8.1, as the DRw6cI-restricted done AL8.1. Similarly, it was found that clones BR7.3 and 22.5 expressed Votl.2, which is closely related to the Voll.10 segment (89% homologous at the amino acid level) used by the DRw6cI-restricted clone AL9.2. However, the TCRs of these pairs of clones differ significantly at their corresponding junctional regions (Fig. 2) . These observations suggest that germline-encoded structural components of the TCR may not be responsible for recognition of the DR polymorphic residues, at least in this particular case, and that junctional region residues can influence MHC specificity. illustrated by the following examples. Gene segments Vc~21 and Vod7 were found to be used not only in association with VB2.1, but with V321.3 (clone ALIID.1) and V~19.1 (done AL7.1), respectively. Similarly, in the TCRs of BR3.5 and BR5.11, Vc~2 family members found associated with V32.1 in DRw6cI-restricted clones could pair with other V3s to generate, this time, a DR4w4-restricted specificity. Thus, despite the frequent use of V32.1 and of some Vo~ segments, a large number of V~V/~ combinations can constitute TCRs recognizing the tt830-844 peptide, even when considering dones specific for this peptide presented in the same HLA-DR context. Indeed, nine and five different V~V/~ pairs were found among 13 DRw6cI-restricted and six DR4w4-restricted clones, respectively.
Apparent Lack of Structural Conservation in the Junctional Regions of anti-it830-844 TCRs. Many different Jot and JB
segments were found to be used by the TCRs analyzed ( Table  2) . We did not notice any particular selection of Jol and J~ sequences that correlated with DR restriction or with the use of the same Vol and/or V~ segments. JB2.5 and JB2.7 were found to be expressed in four and five clones, respectively, and were the most frequently usedJ~ segments. However, they could be associated with V/~2.1, at well as with other VB segments. Jo~ use was more diverse, with a total of 16 different Jc~ segments expressed in the 23 anti-tt830-844 clones analyzed. This may simply reflect the much greater size of the Jc~ versus Jfl repertoire (3), rather than sdection of particular Jfl segments in the anti-tt830-844 response. Although inspection of the nudeotide sequences of the Vfl-D-JB junctions did not always allow a dear assignment of sequences to Dill or Dfl2 segments (40) , the contribution of D sequences to the junctional diversity was dearly different from one clone to another.
The large J repertoire and additional junctional variability due to imprecise joining and N (nudeotides)-region addition was reflected in the highly heterogeneous CDR3 sequences of both Voe and Vfl regions (Fig. 2) . We assigned the boundaries of the putative TCR CDR3 regions according to Chothia et al. (5) . The residues from J sequences contributing to CDR3 are underlined in Fig. 2 . The last position of the putative Va and Vfl CDR3 loops, encoded by the J sequence, is often a Leu and a Gln, respectively. As these residues are normally conserved in the respective J segments (37, (40) (41) (42) , their role is probably to hdp maintain the overall conformation of the CDR3 loops, rather than to directly contact ligand (4, 5) . The first position of the CDR3 equivalent of Vfl2.1 chains was an Arg in 7 of 14 cases. This residue was germline encoded in all cases except for one, where it arose from somatic diversification mechanisms (not shown).
In the V~2.1 chain of clone AL8.1, a conservative Lys for Arg substitution has taken place. However, it is evident that the putative V~ CDK3s of the anti-tt8300844 TCKs analyzed show dramatic differences in both length (6-16 residues) and/or amino acid composition. This is observed even for the junctional regions of TCRs that use members of the same Vc~ family and the same V~ and that are restricted to the same DR., such as clones ALIII4.3, AL17.3, and AL4.1, or BK15.3, BK9.D, and BK7.5 (for AL 4.1 and BR7.5, it is tentatively assumed that Vc~17.1 and Vot2.6, respectively, each pair with V~2.1), or clones AL15.3 and ALIII6.1. The only exception to this striking lack of junctional sequence conservation is represented by clones BK7.3 and BK22.5, which are both restricted to DR4w4, where the use of the same Vc~ and VB gene segments is accompanied by relatively conserved Vo~ CDR3s, both in amino acid composition and in length. Their V~/CDK3s, however, differ markedly. In summary, among the 23 independent clones analyzed, 22 unique VlgD-J~ and 25 unique Vc~-Jc~ junctions were found and, with a single exception, no greater junctional sequence conservation was observed among TCKs with identical Vo~ and/or V~ gene segments than among those with different ones.
Discussion
Previous studies in the mouse system (10018) have demonstrated that, with a notable exception (45), TCRs selected in response to a defined peptide-Ia complex use a restricted number of Vo~/VB gene segment combinations. In the one exception, involving the response to a determinant from influenza virus hemaglutinin, a markedly more diverse TCR repertoire was found. In all these studies, however, TCKs that used the same V region germline gene segments generally expressed closely related (or identical)junctional region amino acid sequences, suggesting that V regions and junctional sequences are functionally coselected. Thus, in the cytochrome c system (15), among nine murine clones expressing V~3, all were found to have the same number of amino acids spanning the V~/-D-J/3 junction, and eight had an asparagine at position 100. Indeed, site-directed mutagenesis of this residue was shown to affect recognition (46) .
To investigate whether a similar structural conservation of TCRs specific for a defined antigen/MHC complex is found in antigen-primed human donors and, at the same time, to obtain further insights into the molecular mechanism of antigen and MHC recognition, we analyzed the TCKs selected in a DR-restricted memory T cell response to the tt epitope tt8300844. Since tt8300844 can be recognized in association with most DR molecules (20) , this system also offered an opportunity to evaluate the influence of changing the antigenpresenting molecule on the selection of TCR variable region components. In addition, the tt830-844 peptide seems to bind to different DR molecules in a similar orientation (20~ This should simplify interpretation of the observed response. Our analysis of a large panel of anti-tt8300844 human T cell clones has revealed repeated use of a particular V~ region gene segment, as often observed in the mouse system. In contrast to previous studies, however, no apparent conservation in the length and/or amino acid composition of Vol or VB junctional regions could be detected, even among TCKs with identical Vo~ and/or VB gene segments.
A particular V~/gene product, VB2.1, was preferentially used by anti-tt8300844-specific TCKs, irrespective of whether the peptide was presented by DK6wcI, DR4w4, or DRw11.1 and DRw11.2 alleles in three of the donors studied. Thus, shared MHC class II antigens are not required for shared V~ gene usage by TCRs specific for this peptide. This result is consistent with the finding by Wucherpfenning et al. (47) that TCKs reactive with an MBP-derived peptide and expressing V~12 or VB17 can be isolated from DR2-, DR3-, or DR4-positive patients. As in the present study, preferential use of a particular V~ gene segment (VB17) in T cell clones specific for this peptide was also found. Another recently described case of restricted TCK gene expression in humans is that of Vod7 use by tumor-infiltrating lymphocytes in uveal melanoma (48) . In this case, however, the nature of the targeted antigen(s) is unknown. In the antitt830-844 response, no preferential use of other Vfls was found in a series of clones not expressing V~2.1, suggesting that the latter is strongly selected, at least in the individuals studied, for interacting with a structural determinant common to the different peptide/DR complexes recognized. These complexes share an identical DR o~ chain, but the corresponding DR chain display 3-11 amino acid substitutions when com-pared with one another (Fig. 4) . According to the proposed structural model of class II MHC (23) , some of these polymorphic residues (on the floor of, or pointing inside the MHC pocket) may influence the way in which the peptide binds to the restricting element, and others (on the top of the DRB c~ helix) may interact with the TCR and are unlikely to influence the determinant seen by V~2.1. Moreover, tt830-844 has been shown to interact with different DR alleles via common residues (21) . It is therefore likely that the promiscuous binding of this peptide is the result of the interaction between these residues and sites conserved in different DR molecules (20, 21) . Given this apparently similar orientation of the peptide in the DR molecules, one would expect that different complexes share, at least in part, a common T cell determinant that can be seen by VB2.1. This hypothesis is favored by the observation that, with one exception, all clones displaying promiscuous recognition use V~2.1 (see Table 2 ). However, further studies will be needed to clarify whether the determinant selecting V~/2.1 is borne by the nonpolymorphic c~ chain of DR or by a common motif of the DR chain, or rather of the peptide, or of both the peptide and DR molecule.
The Vc~ use in the 21 clones analyzed was not biased to only one Vc~ chain, as observed for VB. For instance, if we consider the 10 clones using V~2.1 and restricted to DRw6cI, a minimum of six (to a maximum of eight) different Vot family members could be used to recognize this complex. It is worth noting, however, that Vot2.2., VotS.1 (Vc~8.2), Vc~17.1, and Vot21.1, which are among the Vo~ gene segments most frequently associated with V~2.1, display a significantly higher degree of similarity to each other (50-60% amino acid identity) than to most Vc~ members (<40% identity). Thus, one may speculate that they all share a minimal structural element important in forming a similar antigenic specificity and/or restriction. This possibility is consistent with what is known from sequencing and x-ray crystallographic analysis of anti-phosphorylcboline (49) and antiphenyloxazolone (50) antibodies about how a particular binding specificity may be preserved, even after substitution of a given H (or L) chain by another, apparently unrelated one. In the former case, the H chains are invariably derived from the same V. germline gene, and the L chain sequences may belong to any of three different subgroups (49) . In the latter case, a given H chain may be functionally replaced by a variety of other, seemingly unrelated ones, provided the L chain is retained (50) . In both cases, however, key antigencontacting residues are found to be conserved in the substituted chain. Another possible explanation for the diversity of c~ chains which may be paired with VB2.1-encoded B chains is that recognition is mostly mediated by the ~ chain and that the ot chain plays only a secondary role and so is not functionally selected. In this context, Tan et al. (51) have shown that transfer of the ot chain alone of an arsonate-specific TCR into a recipient T cell with an unrelated B chain is suf~cient to confer responsiveness to the hapten, implying that one chain of the TCR may be functionally dominant over the other in certain cases.
It is interesting that clones expressing the same or very closely related Vc~ and the same VB segments, but displaying distinct junctional amino acid sequences, could recognize tt830-844 in the context of two different DR alleles. It therefore appears that in some cases TCRjunctional regions may dictate the restriction by recognizing either a DR allele-dependent conformation of the peptide or polymorphic residues of the DR ~ chain. A situation in which TCR junctional regions seem critical to recognition of both antigen and MHC has been described by Rupp et al. (52) who found that an alloreactive, H-2Db-specific, cytotoxic T cell clone and a chicken erythrocyte-specific, I-Ab-restricted, helper done share identical Vot and V~ gene segments, but differ in their junctional sequences. Thus, alterations in the putative CDR3 regions of the TCR may affect peptide specificity but not MHC restriction (15) (16) (17) (18) , both antigen recognition and MHC restriction (52), or only MHC specificity but not peptide reactivity, as in the present work.
The most striking finding of this study was the remarkable diversity in the junctional regions of the 23 anti-tt830-844 T cell clones analyzed, even when comparing TCRs composed of identical Vc~ and/or VB gene segments. Thus, among 14 anti-tt830-844 T cell clones using the VB2.1 gene segment, 14 unique VB-D-JB junctions were found, with no evident conservation of length and/or amino acid composition, and with only a single positively charged amino acid residue conserved at the NH~-terminal position of the putative CDR3s of eight of them (Table 2) . However, the fact that this residue is not always conserved, as well as being encoded by the germline VB2.1 gene segment (9) in seven of the eight cases, argues against any particular selection of this residue for recognition. Lack of structural conservation was also found for most of the putative CDR3s of the c~ chains, whether or not they were associated with the same Vot gene segment or were part of TCRs using the same V/3 gene segment. One exception was represented by clones BR7.3 and BR22.5, whose ot chain CDR3 junctions are partially conserved in length and amino acid composition. Here too, however, one finds the substitution of a Gln by a Pro, which may significantly affect the conformation of the CDR3 loop (53) . Moreover, the Vfl CDR3s of these clones differ markedly.
Recently, two studies in the mouse investigating class I-restricted responses to a lymphocytic choriomeningitis virus (LCMV) undecapeptide in a transgenic system (54), and to a Plasmodium berghei nonapeptide (55), found substantially different V~-D-JB junctional regions in the context of a common Vfl. Thus, together with ours, these results indicate that variability in the junctional regions of TCRs specific for an identical peptide/MHC complex is not exceptional and may depend on the particular peptide (or epitope) recognized.
One interpretation for the apparent lack of selection of specific junctional sequences in the context of a common V (Vfl and/or Vc 0 region element is that the junctional regions of these TCRs do not play a major role in recognition of the tt830-844/DR complex and so are not structurally constrained. That the putative CDR.3 regions have at least some influence on recognition, however, is shown by the effect of changes in these regions on DR restriction, as discussed above. In addition, changes in the junctional sequences may alter the affinity or fine specificity of these TCRs. Nevertheless, the strong selection for V~2.1, but not for any particular junctional sequence(s), found in many anti-tt830-844 clones suggests that the former may be responsible for most of the key contacts with the peptide/MHC complex. It is instructive to examine this situation in the light of what is known about the selection of particular CDR. sequences in antibodies. In this case, x-ray crystallographic analysis has shown that the strict maintenance of certain amino acid sequences, such as those at the potentially highly variable VL-JL and V,-D-J, junctions (CDR3s) observed among anti-phosphorylcholine (49) and anti-phenyloxazolone (50) antibodies, is largely due to structural constraints related to antigen recognition. Conversely, CDRs that make no contacts with antigen, such as V, CDR2 of anti-phenyloxazolone antibodies (50), are not functionally restrained and may show extensive sequence variability. An interesting finding in this respect is that an L dreactive cytolytic T cell clone using the same Vc~ segment (Vcr as an I-Aa-restricted arsonate reactive one, but an unrelated V~-Jc~ junction and/3 chain, also responds to this hapten, suggesting that CDR3 sequences may not be critical to arsonate recognition (51) .
Alternatively, our data can be interpreted in terms of recently proposed models for TCR recognition of peptide/MHC complexes in which CDR1 and CDR2 of the V regions interact with MHC determinants, and the CDR3 junctional regions bind to the antigenic peptide (3, 5, 56) . Assuming that all V~2.1-containing TCRs bind to the same tt830-844/DR complex in the same general orientation as the result of conserved contacts between the first two CDRs of this domain and the DR molecule, one is confronted with the obvious difficulty of physically accommodating such highly heterogeneous CDR3s in what is predicted to be the geometrical center of the interface between the TCR and the peptide/MHC complex (3, 5, 56) . This problem is even more difficult for TCRs using the same Voe and V3 segments. One possibility is that the V32.1 CDR3s and Vot CDR3s differing dramatically in primary structure, may actually fold into similar three-dimensional conformations. This, however, appears unlikely based on the similarity between Ig and TCR frameworks (5) and on detailed studies of the conformations of VL and V. CDR3s in antibodies of known three-dimensional structure (53) . An alternative hypothesis to explain CDR3 heterogeneity in TCRs recognizing the same complex is that certain peptides bound to the MHC pocket possess a degree of freedom allowing some of the peptide side chains to assume different conformations (17) . This in turn may result in different complexes selecting the same V regions (which contact the MHC molecule), but very different junctions.
It is also possible that even TCRs using the same V~ (and VoQ germline gene segments may have different views of the same pepdde/DR complex or see different parts of tt830-844, thus explaining the junctional variability observed. However, preliminary studies examining the effects of multiple substitutions at every position of tt830-844 on recognition by some of the VB2.1-expressing clones reported here indicate that the segment seen by these clones does not include the NH2-terminal (Q) and the last four COOH-terminal (ITEL) residues of tt830-844. Furthermore, these clones are all affected by substitutions in the central region of the tt830-844, indicating that they interact with the same stretch of the peptide.
Finally, it is conceivable that in our particular case the peptide/MHC complex may be heavily tilted toward the VB domain and yet maintain the same overall alignment relative to the latter, as in the proposed models (4, 5, 56) . This would have the effect of partially disengaging V~ CDR3 (as well as the entire Vo~ domain) from the interface between the TCtL and the peptide-MHC complex, and potentially allowing for greater sequence variability at the V/~-D-J~ junction. It is interesting that cases of asymmetrical positioning of the antibody heterodimer on the surface of antigen, resulting in markedly unequal contributions of VL versus V. domains to formation of the interface with antigen, have been well documented in x-ray crystallographic studies of antigenantibody complexes (57, 58) .
Further experiments involving the use of analogues of tt830-844 carrying a large number of substitutions, as well as TCR reconstitutions by transfection employing different combinations of ot and/3 chains, should help to distinguish among these possibilities.
To our knowledge, the present study represents the most extensive analysis to date illustrating the complexity of TCR structural components repertoire selected for a well-defined epitope in the human. In addition, this system represents a useful model for further understanding the rules governing T cell recognition.
